Tags

Type your tag names separated by a space and hit enter

SARS-associated coronavirus transmission, United States.
Emerg Infect Dis. 2004 Feb; 10(2):225-31.EI

Abstract

To better assess the risk for transmission of the severe acute respiratory syndrome-associated coronavirus (SARS-CoV), we obtained serial specimens and clinical and exposure data from seven confirmed U.S. SARS patients and their 10 household contacts. SARS-CoV was detected in a day-14 sputum specimen from one case-patient and in five stool specimens from two case-patients. In one case-patient, SARS-CoV persisted in stool for at least 26 days after symptom onset. The highest amounts of virus were in the day-14 sputum sample and a day-14 stool sample. Residual respiratory symptoms were still present in recovered SARS case-patients 2 months after illness onset. Possible transmission of SARS-CoV occurred in one household contact, but this person had also traveled to a SARS-affected area. The data suggest that SARS-CoV is not always transmitted efficiently. Routine collection and testing of stool and sputum specimens of probable SARS case-patients may help the early detection of SARS-CoV infection.

Authors+Show Affiliations

Epidemic Intelligence Service, Centers for Disease Control and Prevention, Atlanta, Georgia 30333, USA. iae4@cdc.govNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info available

Pub Type(s)

Journal Article

Language

eng

PubMed ID

15030687

Citation

Isakbaeva, Elmira T., et al. "SARS-associated Coronavirus Transmission, United States." Emerging Infectious Diseases, vol. 10, no. 2, 2004, pp. 225-31.
Isakbaeva ET, Khetsuriani N, Beard RS, et al. SARS-associated coronavirus transmission, United States. Emerg Infect Dis. 2004;10(2):225-31.
Isakbaeva, E. T., Khetsuriani, N., Beard, R. S., Peck, A., Erdman, D., Monroe, S. S., Tong, S., Ksiazek, T. G., Lowther, S., Pandya-Smith, I., Anderson, L. J., Lingappa, J., & Widdowson, M. A. (2004). SARS-associated coronavirus transmission, United States. Emerging Infectious Diseases, 10(2), 225-31.
Isakbaeva ET, et al. SARS-associated Coronavirus Transmission, United States. Emerg Infect Dis. 2004;10(2):225-31. PubMed PMID: 15030687.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - SARS-associated coronavirus transmission, United States. AU - Isakbaeva,Elmira T, AU - Khetsuriani,Nino, AU - Beard,R Suzanne, AU - Peck,Angela, AU - Erdman,Dean, AU - Monroe,Stephan S, AU - Tong,Suxiang, AU - Ksiazek,Thomas G, AU - Lowther,Sara, AU - Pandya-Smith,Indra, AU - Anderson,Larry J, AU - Lingappa,Jairam, AU - Widdowson,Marc-Alain, AU - ,, PY - 2004/3/20/pubmed PY - 2004/5/12/medline PY - 2004/3/20/entrez SP - 225 EP - 31 JF - Emerging infectious diseases JO - Emerg Infect Dis VL - 10 IS - 2 N2 - To better assess the risk for transmission of the severe acute respiratory syndrome-associated coronavirus (SARS-CoV), we obtained serial specimens and clinical and exposure data from seven confirmed U.S. SARS patients and their 10 household contacts. SARS-CoV was detected in a day-14 sputum specimen from one case-patient and in five stool specimens from two case-patients. In one case-patient, SARS-CoV persisted in stool for at least 26 days after symptom onset. The highest amounts of virus were in the day-14 sputum sample and a day-14 stool sample. Residual respiratory symptoms were still present in recovered SARS case-patients 2 months after illness onset. Possible transmission of SARS-CoV occurred in one household contact, but this person had also traveled to a SARS-affected area. The data suggest that SARS-CoV is not always transmitted efficiently. Routine collection and testing of stool and sputum specimens of probable SARS case-patients may help the early detection of SARS-CoV infection. SN - 1080-6040 UR - https://www.unboundmedicine.com/medline/citation/15030687/SARS_associated_coronavirus_transmission_United_States_ DB - PRIME DP - Unbound Medicine ER -